0 results for 'Amgen'
FOIA Claims Dismissed Based on Res Judicata, New Trial Granted and Qui Tam Claims
This column reports on several recent significant decisions from the United States District Court for the Eastern District of New York. Judge Natasha C. Merle dismissed claims based on res judicata. Judge Frederic Block granted a motion for a new trial due to an excessive damage award. And Judge Brian M. Cogan dismissed qui tam claims under the False Claims Act for lack of subject matter jurisdiction.DLA Piper Exhibited 'Far From Exemplary Conduct' in Patent Infringement Case, Judge Finds
A Delaware federal judge found that the firm could keep representing a plaintiff even though it also counsels the defendant's parent company. The opinion could have broader implications for firms and attorneys representing multi-layered businesses.Litigation Department of the Year (General) Winner: Cravath, Swaine & Moore
"At every step, we place paramount focus on our clients' business needs and goals."Who Got the Work: Saul Ewing Team Appears for Samsung Bioepis in Amgen Patent Case
California-based Amgen has filed a patent infringement suit to stop Samsung Bioepis from developing bone-treatment drugs that would rival two of its top-performing products.'Monopoly Prices'?: Big Pharma Co. Amgen Accused of Anticompetitive Conduct
"A 50-mg dose of Enbrel now costs patients $7,401.83 per month: 643% more than it cost when launched in 1998," according to the allegations in the antitrust class action filed against Enbrel manufacturer Amgen Inc.View more book results for the query "Amgen"
In Absence of a 502(d) Order, Court Finds Waiver of Privilege
In their Federal E-Discovery column, Christopher Boehning and Daniel Toal discuss the recent decision "United States ex rel. Omni Healthcare, Inc. v. MD Spine Solutions" which "raises some interesting questions and implications for practitioners and judges dealing with privilege issues in e-discovery."Litigation Leaders: Don McMinn of Hollingsworth on Going Where the Work Takes You
"We have argued before federal and state courts nationwide, and we do not shy away from going toe-to-toe with plaintiffs' counsel in their preferred home-turf courthouses, whether that be suburban California or small-town Mississippi."The Real Impact of the Biden Era on M&A
"Changes in the merger review process has undoubtedly increased the cost and resource burden on merging parties," write Elizabeth Suarez, Kaylynn Moss and Terry Calvani.Lawsuits Are Flying Over Generic-Drug Disputes: Surge in Patent Litigation
Five of the suits were filed by Esperion Therapeutics, which seeks to stop competitors from selling generic versions of the company's cholesterol drug Nexletol.Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
Why Embracing Change Is Essential for Your Legal Department
Brought to you by DiliTrust
Download Now
International Export and Trade Assistance State Law Survey
Brought to you by LexisNexis®
Download Now
How This Personal Injury Firm Reduced Client Intake Time by 80%
Brought to you by PracticePanther
Download Now
The Hidden Cost of Bad Reviews: Why Law Firms & Attorneys Can't Afford a Damaged Online Reputation
Brought to you by Erase.com
Download Now